Lupin Limited
| Company type | Public |
|---|---|
| BSE: 500257 NSE: LUPIN | |
| Industry | Pharmaceuticals |
| Founded | 1968 |
| Founder | Desh Bandhu Gupta |
| Headquarters | , India |
Key people | Vinita D. Gupta (CEO) Nilesh Gupta (MD) |
| Products | |
| Revenue | ₹19,656 crore (US$2.3 billion) (FY24) |
| ₹3,800 crore (US$450 million) (FY24) | |
| ₹1,914 crore (US$230 million) (FY24) | |
| Total assets | ₹22,955 crore (US$2.7 billion) (2023) |
| Total equity | ₹12,464 crore (US$1.5 billion) (2023) |
Number of employees | 20,000+ (2023) |
| Website | www |
| Footnotes / references | |
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.